Overview
An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy
Status:
Completed
Completed
Trial end date:
2012-04-01
2012-04-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to assess the tolerability of AVANZ.Phase:
Phase 2/Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
ALK-Abelló A/S
Criteria
Inclusion Criteria:- History of grass pollen rhinoconjunctivitis
- Positive SPT to Phleum pratense
- Positive specific IgE against Phleum pratense
Exclusion Criteria:
- Uncontrolled severe asthma